Harms in Systematic Reviews Paper 1: An introduction to research on harms

被引:26
|
作者
Qureshi, Riaz [1 ]
Mayo-Wilson, Evan [2 ]
Li, Tianjing [3 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Indiana Univ Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, ID USA
[3] Univ Colorado Anschutz Med Campus, Dept Ophthalmol, Aurora, CO USA
关键词
Harms; Systematic Reviews; Meta-analysis; Synthesis; Clinical Trials; RANDOMIZED CONTROLLED-TRIALS; REAL-WORLD; CLINICAL-TRIALS; ADVERSE EVENTS; SAFETY; METAANALYSIS; OUTCOMES; INTERVENTION; CHALLENGES; POOR;
D O I
10.1016/j.jclinepi.2021.10.023
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Most systematic reviews of interventions focus on potential benefits. Common methods and assumptions that are appropriate for assessing benefits can be inappropriate for harms. This paper provides a primer on researching harms, particularly in systematic reviews.Study Design and Setting: Commentary describing challenges with assessing harm.Results: Investigators should be familiar with various terminologies used to describe, classify, and group harms. Published reports of clinical trials include limited information about harms, so systematic reviewers should not depend on these studies and journal articles to reach conclusions about harms. Visualizations might improve communication of multiple dimensions of harms such as severity, relatedness, and timing.Conclusion: The terminology, classification, detection, collection, and reporting of harms create unique challenges that take time, expertise, and resources to navigate in both primary studies and evidence syntheses. Systematic reviewers might reach incorrect conclusions if they focus on evidence about harms found in published reports of randomized trials of a particular health problem. Systematic reviews could be improved through better identification and reporting of harms in primary studies and through better training and uptake of appropriate methods for synthesizing evidence about harms.(c) 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license ( http:// creativecommons.org/ licenses/ by/ 4.0/ )
引用
下载
收藏
页码:186 / 196
页数:11
相关论文
共 50 条
  • [31] Side Effects Are Side Issues: Completeness of Reporting of Harms Among Systematic Reviews in Gastroenterology
    Mahady, Suzanne E.
    Schlub, Timothy E.
    Bero, Lisa
    George, Jacob
    Craig, Jonathan
    GASTROENTEROLOGY, 2014, 146 (05) : S558 - S558
  • [32] Interests and Harms in Primate Research
    Nobis, Nathan
    AMERICAN JOURNAL OF BIOETHICS, 2009, 9 (05): : 27 - 29
  • [33] INTRODUCTION TO PHONOLOGICAL THEORY - HARMS,RT
    MURAKI, M
    FOUNDATIONS OF LANGUAGE, 1972, 9 (02): : 254 - 261
  • [34] Research Ethics and Private Harms
    Koocher, Gerald P.
    JOURNAL OF INTERPERSONAL VIOLENCE, 2014, 29 (18) : 3267 - 3276
  • [35] Evidence for harms of high tidal volumes from systematic reviews and meta-analysis - a reply
    Charlesworth, M.
    ANAESTHESIA, 2019, 74 (08) : 1071 - 1071
  • [36] Availability of large-scale evidence on specific harms from systematic reviews of randomized trials
    Papanikolaou, PN
    Ioannidis, JPA
    AMERICAN JOURNAL OF MEDICINE, 2004, 117 (08): : 582 - 589
  • [37] Harms reporting by systematic reviews for functional endoscopic sinus surgery: a cross-sectional analysis
    Jones, Garrett
    Hemmerich, Christian
    Rucker, Brayden
    Wise, Audrey
    Kee, Micah
    Johnson, Austin
    Brame, Lacy
    Hamilton, Tom
    Vassar, Matt
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2023, 280 (06) : 2805 - 2819
  • [38] Harms reporting by systematic reviews for functional endoscopic sinus surgery: a cross-sectional analysis
    Garrett Jones
    Christian Hemmerich
    Brayden Rucker
    Audrey Wise
    Micah Kee
    Austin Johnson
    Lacy Brame
    Tom Hamilton
    Matt Vassar
    European Archives of Oto-Rhino-Laryngology, 2023, 280 : 2805 - 2819
  • [39] Balancing benefits and harms in health care - Observational data on harm are already included in systematic reviews
    Jefferson, T
    Demicheli, V
    BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7417): : 750 - 750
  • [40] The reporting of safety among drug systematic reviews was poor before the implementation of the PRISMA harms checklist
    Li, Ling
    Xu, Chang
    Deng, Ke
    Zhou, Xu
    Liu, Zhibin
    Busse, Jason W.
    Ren, Yan
    Zou, Kang
    Sun, Xin
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2019, 105 : 125 - 135